CD86 (CD86 Antigen, Activation B7-2 Antigen, B Lymphocyte Activation Antigen B7-2, B7-2, B7-2 Antigen, B70, BU63, CD28 Antigen Ligand 2, CD28LG2, CTLA-4 Counter Receptor B7-2, CTLA-4 Counter-receptor B7.2, FUN 1, FUN-1, LAB72, MGC34413, T-lymphocyte Activation Antigen CD86) (FITC)

CD86 has been identified, along with CD80 (B7-1), as a ligand for CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA4). CD28 and CTLA4 are two receptors that have opposing functions in T-cell stimulation. Interaction of CD86 with CD28 promotes a number of T-cell activities, whereas the binding of CD86 to CTLA4 inhibits T-cell responses.||Applications:|Suitable for use in Flow Cytometry. Other applications not tested.||Recommended Dilution:|Flow Cytometry: 10ul labels 10e6 cells in 100ul|Optimal dilutions to be determined by the researcher.||Storage and Stability:|Store product at 4°C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C. Aliquots are stable at -20°C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. |Caution: FITC conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.